Conmed (FRA:EC8) Inventories, Raw Materials & Components: €100 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:EC8 Conmed Corp FRA:EC8
81 GF Score
Price €43.80
GF Value €57.51
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Conmed Inventories, Raw Materials & Components?

Conmed FRA:EC8 81 Inventories, Raw Materials & Components is €100 Mil as of Jun. 2026. GuruFocus rates FRA:EC8 with a GF Score™ of 81/100 and a GF Value™ of €57.51 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Conmed's inventories, raw materials & components for the quarter that ended in Jun. 2026 was €100 Mil.

Conmed's quarterly raw materials increased from Dec. 2025 (€94 Mil) to Mar. 2026 (€97 Mil) and increased from Mar. 2026 (€97 Mil) to Jun. 2026 (€100 Mil).

Conmed's annual raw materials increased from Dec. 2023 (€98 Mil) to Dec. 2024 (€110 Mil) but then declined from Dec. 2024 (€110 Mil) to Dec. 2025 (€94 Mil).

Conmed Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Conmed's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Conmed Inventories, Raw Materials & Components Chart

Conmed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 73.80 104.48 98.36 109.57 93.62

Conmed Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 95.49 86.76 93.62 97.17 100.32
FRA:EC8
81GF Score
Conmed Corp FRA:EC8
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Conmed Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of €100 Mil mean?
Conmed (FRA:EC8) has a Inventories, Raw Materials & Components of €100 Mil as of Jun. 2026. Raw materials are the components a company uses for its main products. View historical data on Conmed and its competitors.
Is Conmed's Inventories, Raw Materials & Components too high?
Conmed's current Inventories, Raw Materials & Components is €100 Mil. Overall, Conmed has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Conmed's Inventories, Raw Materials & Components compare to ATEC and AORT?
Conmed's Inventories, Raw Materials & Components of €100 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Devices & Instruments company?
A good Inventories, Raw Materials & Components depends on the Medical Devices & Instruments industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Conmed and its competitors. Conmed's current Inventories, Raw Materials & Components is €100 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Conmed stock overvalued right now?
Based on GuruFocus' analysis, Conmed (FRA:EC8) is currently considered Modestly Undervalued. The stock's GF Value™ is €57.51, compared to a current price of €43.80 — trading 23.8% below its estimated fair value. The current Inventories, Raw Materials & Components is €100 Mil. Conmed's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Conmed (FRA:EC8), the current Inventories, Raw Materials & Components is €100 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Conmed (FRA:EC8) Overvalued in 2026?

Based on GuruFocus' analysis, Conmed stock appears to be undervalued. The current stock price of €43.80 is trading 23.8% below its estimated GF Value™ of €57.51. GuruFocus considers Conmed to be Modestly Undervalued.

Key valuation signals for FRA:EC8:

  • Inventories, Raw Materials & Components: €100 Mil
  • GF Value™: €57.51 vs. price of €43.80 (23.8% below fair value)
  • GF Score™: 81/100 with 5 warning signs

No single metric tells the full story. See the FRA:EC8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Conmed Business Description

Other Exchanges CNMD:USA
Address 11311 Concept Boulevard, Largo, FL, USA, 33773
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
81GF Score

Get the complete analysis for FRA:EC8

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€43.80
Price
€57.51
GF Value